[go: up one dir, main page]

Holford et al., 1981 - Google Patents

The effect of quinidine and its metabolites on the electrocardiogram and systolic time intervals: concentration‐effect relationships.

Holford et al., 1981

View PDF
Document ID
10970400370703633603
Author
Holford N
Coates P
Guentert T
Riegelman S
Sheiner L
Publication year
Publication venue
British journal of clinical pharmacology

External Links

Snippet

1 A combined pharmacokinetic and pharmacodynamic model has been used to analyze the relationship between electrocardiographic (ECG) and systolic time intervals (STI) and changes in plasma concentration of quinidine after oral and iv doses in ten normal subjects …
Continue reading at bpspubs.onlinelibrary.wiley.com (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/04—Detecting, measuring or recording bioelectric signals of the body of parts thereof
    • A61B5/0402—Electrocardiography, i.e. ECG
    • A61B5/0452—Detecting specific parameters of the electrocardiograph cycle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radiowaves
    • A61B5/053—Measuring electrical impedance or conductance of a portion of the body
    • A61B5/0535—Measuring electrical impedance or conductance of a portion of the body impedance plethysmography
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
    • A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems

Similar Documents

Publication Publication Date Title
Holford et al. The effect of quinidine and its metabolites on the electrocardiogram and systolic time intervals: concentration‐effect relationships.
Kim et al. Poisoning due to class IA antiarrhythmic drugs: quinidine, procainamide and disopyramide
Iisalo Clinical pharmacokinetics of digoxin
Forsman et al. Applied pharmacokinetics of haloperidol in man.
McAllister Jr et al. The pharmacology of verapamil. IV. Kinetic and dynamic effects after single intravenous and oral doses
Galeazzi et al. Relationship between the pharmacokinetics and pharmacodynamics of procainamide
Keefe et al. New antiarrhythmic drugs: their place in therapy
Scott et al. Acute toxicity of ropivacaine compared with that of bupivacaine
Strauss et al. Electrophysiologic effects of propranolol on sinus node function in patients with sinus node dysfunction.
Farshidi et al. Repetitive responses to ventricular extrastimuli: incidence, mechanism, and significance
Taylor et al. Cardiac effects of tricyclic antidepressant medication. A preliminary study of nortriptyline.
White et al. Pharmacokinetics of intravenous amodiaquine.
Brown et al. Therapeutic drug monitoring of antiarrhythmic agents
Rakhit et al. Pharmacokinetics of quinidine and three of its metabolites in man
Li et al. Systolic time intervals in clinical pharmacology
Surawicz Electrolytes and the electrocardiogram
Meffin et al. Acebutolol disposition after intravenous administration
Thibonnier et al. Pharmacokinetic-pharmacodynamic analysis of unbound disopyramide directly measured in serial plasma samples in man
Pan et al. Cocaine and alcohol interactions in the rat: effect on cocaine pharmacokinetics and pharmacodynamics
Ellenbogen et al. Frequency-dependent effects of verapamil on atrioventricular nodal conduction in man.
Gilmore et al. Influence of interstimulus interval on myocardial potassium balance
Lalonde Pharmacokinetic-pharmacodynamic relationships of cardiovascular drugs
Huang et al. IV bolus administration of subconvulsive doses of lignocaine to conscious sheep: myocardial pharmacokinetics
Wooding‐Scott et al. The pharmacokinetics and pharmacodynamics of quinidine and 3‐hydroxyquinidine.
Ishizaki et al. Prediction of changes in the clinical pharmacokinetics of basic drugs on the basis of octanol‐water partition coefficients